Safety, accuracy, empathy, reliability, and readability of large language model responses to patient health questions about adenomyosis: A comparative study
Other
OA: bronze
public-domain-us
Abstract
BACKGROUND: Patients increasingly use large language model (LLM)-based chatbots to seek health information. Adenomyosis is a common gynecological condition associated with heavy menstrual bleeding, dysmenorrhea, pelvic pain, infertility, and pregnancy-related concerns. The quality and safety of chatbot-generated patient information is clinically relevant.
OBJECTIVE: Our objective was to compare the safety, accuracy, empathy, reliability, information quality, and readability of LLM responses to patient health questions about adenomyosis.
METHODS: This comparative cross-sectional evaluation was designed and reported according to the CHART checklist for chatbot health advice studies. Standardized chatbot queries were posed from June 13 to June 15, 2026, in Wuhan, China. A 40-item adenomyosis patient question set was submitted to four LLM-based chatbots: ChatGPT, Gemini, DeepSeek, and Doubao. Five trained gynecology experts evaluated the safety, accuracy, empathy, DISCERN score, EQIP (Ensuring Quality Information for Patients) score, Journal of the American Medical Association (JAMA) benchmark criteria, and Global Quality Scale score using prespecified criteria; readability was calculated algorithmically using automated text-processing procedures. Safety was coded as 0 for safe and 1 for potentially unsafe. Inter-rater agreement was assessed using Fleiss' kappa for safety and intraclass correlation coefficient (2,1) for the remaining expert-rated metrics. Between-model comparisons used paired nonparametric methods, with Kendall's W and 95% confidence intervals reported as the omnibus effect-size measure for Friedman tests.
RESULTS: A total of 160 model-question responses were evaluated. Inter-rater agreement was substantial to excellent across metrics, with Fleiss' kappa of 0.892 for safety and intraclass correlation coefficient values ranging from 0.768 to 0.886 for the remaining metrics. Most responses were classified as safe; observed safe-response proportions differed descriptively across models, and no pairwise safety comparison remained statistically significant after Benjamini-Hochberg adjustment. Accuracy and empathy differed significantly among models (both P < 0.001): ChatGPT achieved the highest median accuracy score. DISCERN, EQIP, and JAMA scores differed significantly among models, whereas Global Quality Scale scores did not. All readability indices differed significantly among models: Doubao had the highest grade-level readability scores and the lowest Flesch Reading Ease score, whereas Gemini had comparatively easier readability.
CONCLUSIONS: LLMs produced generally safe and moderately high-quality responses to adenomyosis-related patient questions, but performance varied by model and by evaluation domain. These findings support the need for transparent, multidimensional assessment of LLM-generated health advice before patient-facing use.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (32)
- Adenomyosis and Infertility: A Literature Review via openalex
- Advances in non-invasive diagnosis of uterine adenomyosis: a narrative review via openalex
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society via openalex
- Guideline No. 437: Diagnosis and Management of Adenomyosis via openalex
- Prevalence of adenomyosis in symptomatic adolescents and young women: a systematic review and meta-analysis via openalex
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis via openalex
- W4361011352 via openalex
- W4367310920 via openalex
- W4385202020 via openalex
- W4387640260 via openalex
- W4388625750 via openalex
- W4391311816 via openalex
- W4400453027 via openalex
- W4402170422 via openalex
- W4403420208 via openalex
- W4403583423 via openalex
- W4406152279 via openalex
- W4406634088 via openalex
- W4407135263 via openalex
- W4409773416 via openalex
- W4412822443 via openalex
- W4415407986 via openalex
- W4416392989 via openalex
- W7125513731 via openalex
- W7128782475 via openalex
- W1963659399 via openalex
- W7154366285 via openalex
- W1967390364 via openalex
- W2022157578 via openalex
- W2123109647 via openalex
- W2396291300 via openalex
- W4319662928 via openalex
Source provenance
- europepmc
- last seen: 2026-11-13T07:00:47.251693+00:00
- openalex
- last seen: 2026-11-13T06:53:04.716285+00:00
- pubmed
- last seen: 2026-11-13T06:54:48.021411+00:00
- unpaywall
- last seen: 2026-11-12T06:32:18.685444+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine